FDA & Compliance

Cosmetic vs Drug: When Does the FDA Consider Your Product a Drug?

You formulated a serum with retinol and niacinamide. You want to say it "reduces wrinkles" and "clears acne." But the moment you make those claims, the FDA may classify your cosmetic product as a drug — and that changes everything about how you can manufacture, label, and sell it. Understanding the cosmetic-drug boundary is one of the most important regulatory decisions a health and beauty brand founder will make.

The Legal Definitions

Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), the definitions are distinct:

Cosmetic: "Articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance."

Drug: "Articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease" and "articles (other than food) intended to affect the structure or any function of the body."

The critical word in both definitions is "intended." The FDA determines a product's intended use based on claims made on the label, in advertising, on websites, and in any promotional materials. The same physical product can be a cosmetic or a drug depending entirely on how you market it.

Claims That Cross the Line

Here are common claims and how the FDA views them:

• Cosmetic claim (OK): "Moisturizes and softens skin" — alters appearance, does not claim to affect body structure
• Drug claim (NOT OK without OTC compliance): "Reduces wrinkles" — implies structural change to skin
• Cosmetic: "Makes skin look brighter"
• Drug: "Lightens dark spots" or "Treats hyperpigmentation"
• Cosmetic: "Gently cleanses without stripping"
• Drug: "Treats acne" or "Kills acne-causing bacteria"
• Cosmetic: "Conditions and strengthens hair" (appearance)
• Drug: "Prevents hair loss" or "Stimulates hair growth"
• Cosmetic: "Refreshes and soothes tired-looking skin"
• Drug: "Anti-inflammatory" or "Heals damaged skin"

Products That Are Both: Cosmetic-Drug Combinations

Some products qualify as both cosmetics and drugs. The most common examples:

• Sunscreens: The tinted moisturizer that beautifies (cosmetic) AND protects from UV radiation (drug)
• Anti-dandruff shampoos: Cleanses hair (cosmetic) AND treats dandruff (drug)
• Acne face washes: Cleanses skin (cosmetic) AND contains salicylic acid to treat acne (drug)
• Fluoride toothpaste: Freshens breath (cosmetic) AND prevents cavities (drug)
• Antiperspirants: Deodorizes (cosmetic) AND reduces perspiration (drug)

When a product is both a cosmetic and a drug, it must comply with the requirements for both categories. This means FDA pre-market approval or compliance with an OTC drug monograph, drug establishment registration, drug listing, drug labeling requirements (including Drug Facts panel), cGMP for drugs (21 CFR Parts 210 and 211, which are more stringent than cosmetic GMP), and adverse event reporting.

The OTC Drug Monograph Path

If your product qualifies as a drug, the most practical path for most beauty brands is the OTC (over-the-counter) drug monograph system. FDA monographs specify which active ingredients are "generally recognized as safe and effective" (GRASE) for specific drug categories, along with permitted concentrations, labeling requirements, and testing standards.

Common OTC monograph categories relevant to beauty brands:

• Sunscreen (UV filters): Specific approved actives (zinc oxide, titanium dioxide, avobenzone, etc.) at specified concentrations with required SPF testing
• Acne treatment: Salicylic acid (0.5–2%), benzoyl peroxide (2.5–10%)
• Skin protectant: Dimethicone (1–30%), petrolatum (30–100%), allantoin (0.5–2%)
• Anti-dandruff: Pyrithione zinc, selenium sulfide, salicylic acid

If your active ingredient is covered by a monograph and you follow all its requirements, you do not need to file a New Drug Application (NDA) — which would cost millions and take years.

Ingredients That Do Not Determine Classification

A common misconception: the ingredient itself does not determine whether your product is a cosmetic or drug. Retinol, for example, can be in a cosmetic product if you market it for appearance benefits ("visibly smooths fine lines for a more youthful look"). But if you claim it "treats wrinkles" or "increases collagen production," you have crossed into drug territory.

Similarly, niacinamide in a cosmetic can "improve the appearance of uneven skin tone," but it cannot "treat rosacea" or "repair the skin barrier." The ingredient does not change — the classification changes based on what you say about it.

Practical Strategies for Beauty Brands

1. Decide your classification early. Before formulation begins, decide whether you are building a cosmetic, an OTC drug, or a combination product. This decision affects your manufacturing requirements, labeling, claims, and timeline.
2. Write claims before formulating. Start with the marketing claims you want to make, then work backward to ensure your product and classification support those claims legally.
3. Use appearance language for cosmetics. Words like "look," "appear," "visibly," and "the appearance of" signal cosmetic intent. Words like "treat," "cure," "heal," "repair," and "prevent" signal drug intent.
4. Audit everything. Your classification is determined by the totality of your marketing — label, website, social media, influencer content, Amazon listing. One drug claim on an Instagram post can reclassify your entire product.
5. Consult before you launch. A regulatory consultant can review your formulation, claims, and labeling to confirm your product's classification and ensure compliance.

How CoreXponent Navigates the Cosmetic-Drug Line

At CoreXponent, we help health and beauty brands determine the right regulatory classification from day one. Whether you are building a pure cosmetic or need to navigate OTC drug monograph requirements, our team ensures your formulation, labeling, and marketing claims are aligned and compliant — so you launch with confidence instead of regulatory risk.